Houston has long been known for its medical and research institutions. These institutions have grown into a catalyst for an end-to-end biotechnology ecosystem where companies can discover, develop, clinically validate and manufacture new therapies without leaving the region.
That evolution will be front and center during the Future of Biotech Expo, held in Houston on August 19-20. The event will bring together pharmaceutical companies, biotech firms, contract research organizations, researchers and technology leaders to explore the future of drug development, clinical trials and emerging technologies.
Partnership Sr. Director of Global Life Sciences Verena Kallhoff, PhD, MBA will be taking part in a panel focusing on Shaping the Biotechnology Landscape in Texas with representatives from the Texas Medical Center, BioHouston and the University of Houston Technology Bridge.
Read more: Lilly Acquires CrossBridge Bio for $300M
Built for Innovation and Scale
“On Houston’s role in red biotechnology, what really sets it apart is how tightly integrated the ecosystem is,” Obair Qadri, Project Lead for the Future of Biotech Expo said. “Institutions like the Texas Medical Center act as a central anchor, bringing together research, clinical care, and commercialization in one place. That proximity allows innovation, particularly in therapeutics, to move more efficiently from lab to clinic.”
Investments across the region are strengthening Houston’s ability to manufacture and scale new therapies. Eli Lilly’s planned manufacturing campus at Generation Park, along with continued expansion of innovation-focused infrastructure, reflects growing confidence in Houston’s life sciences industry. That momentum is also evident in funding. Houston’s life sciences and biotech ecosystem has amassed more than $2 billion in venture capital funding since 2019.
Growth Across High-Impact Biotech Sectors
Houston continues to build on its global leadership in oncology while expanding into several of biotechnology’s fastest-growing fields, including cell and gene therapy, biologics and biomanufacturing, precision medicine, molecular diagnostics, AI-driven drug discovery.
As biology and artificial intelligence become increasingly interconnected, demand is also growing for GMP manufacturing, advanced laboratory space, high-quality clinical data and talent that combines expertise in both biology and data science.
Learn more about Houston’s life sciences and biotechnology ecosystem.